Correlation Between Marker Therapeutics and Agenus

Can any of the company-specific risk be diversified away by investing in both Marker Therapeutics and Agenus at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Marker Therapeutics and Agenus into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Marker Therapeutics and Agenus Inc, you can compare the effects of market volatilities on Marker Therapeutics and Agenus and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Marker Therapeutics with a short position of Agenus. Check out your portfolio center. Please also check ongoing floating volatility patterns of Marker Therapeutics and Agenus.

Diversification Opportunities for Marker Therapeutics and Agenus

0.35

Correlation Coefficient

Marker Therapeutics  Agenus

Weak diversification

The 3 months correlation between Marker and Agenus is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding Marker Therapeutics and Agenus Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Agenus Inc and Marker Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Marker Therapeutics are associated (or correlated) with Agenus. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Agenus Inc has no effect on the direction of Marker Therapeutics i.e., Marker Therapeutics and Agenus go up and down completely randomly.

Pair Corralation between Marker Therapeutics and Agenus

Given the investment horizon of 90 days Marker Therapeutics is expected to under-perform the Agenus. In addition to that, Marker Therapeutics is 1.41 times more volatile than Agenus Inc. It trades about -0.15 of its total potential returns per unit of risk. Agenus Inc is currently generating about -0.12 per unit of volatility. If you would invest  269.00  in Agenus Inc on December 29, 2024 and sell it today you would lose (103.00) from holding Agenus Inc or give up 38.29% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Marker Therapeutics  vs.  Agenus Inc

Marker Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Marker Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Even with unfluctuating performance in the last few months, the Stock's forward-looking signals remain relatively invariable which may send shares a bit higher in April 2025. The latest agitation may also be a sign of long-running up-swing for the enterprise retail investors.

Agenus Inc

Risk-Adjusted Performance

Very Weak

Over the last 90 days Agenus Inc has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Pair Trading with Marker Therapeutics and Agenus

The main advantage of trading using opposite Marker Therapeutics and Agenus positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Marker Therapeutics position performs unexpectedly, Agenus can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Agenus will offset losses from the drop in Agenus' long position.

The idea behind Marker Therapeutics and Agenus Inc pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.